Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

LRCX holding history

Lam Research Corp in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LRCX overview All 13F holders of LRCX Full Q2 2022 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of LRCX by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−76−100.0%	Sold out	Holders
Q1 2022	76	$40.9K	<0.1%	00.0%	Unchanged	Holders
Q4 2021	76	$54.7K	<0.1%	+76	New	Holders
Q2 2021	0	$0	0.0%	−37−100.0%	Sold out	Holders
Q1 2021	37	$22.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.